<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04278625</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00000766</org_study_id>
    <nct_id>NCT04278625</nct_id>
  </id_info>
  <brief_title>Pharmacokinetics of Acetaminophen in Pediatric Patients With Congenital Heart Disease</brief_title>
  <official_title>Pharmacokinetics of Acetaminophen in Pediatric Patients With Congenital Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peter Winch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective study of pediatric patients with congenital heart disease, in which
      acetaminophen serum concentrations will be measured following a single intraoperative
      intravenous dose of acetaminophen. These levels will be used to develop a pharmacokinetic
      model. Serum concentrations will be compared between two groups of patients: (1) cyanotic
      patients presenting for the Fontan completion operation and (2) patients with acyanotic
      congenital heart disease presenting for repair via median sternotomy.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Acetaminophen Serum Concentrations</measure>
    <time_frame>15-20 minutes; 30-40 minutes; 50-70 minutes; 80-100 minutes; 2 Hours, 4 Hours; and 6-Hours Post-IV acetaminophen administration</time_frame>
    <description>To determine the change in serum concentration of acetaminophen between each timepoint.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>Cyanotic CHD</arm_group_label>
    <description>Cyanotic congenital heart disease (CHD) patients presenting for Fontan palliation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acyanotic CHD</arm_group_label>
    <description>Acyanotic congenital heart disease (CHD) patients presenting for repair via median sternotomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>IV acetaminophen given as part of standard of care.</description>
    <arm_group_label>Acyanotic CHD</arm_group_label>
    <arm_group_label>Cyanotic CHD</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric congenital heard disease patients undergoing cardiac surgery and receiving IV
        acetaminophen during their surgical procedure as standard of care.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting for Fontan palliation or for surgical repair requiring median
             sternotomy, will be included in the study.

          -  Only patients who receive intravenous acetaminophen in the operating room will have
             serum levels drawn.

        Exclusion Criteria:

          -  Documentation of an allergy to acetaminophen

          -  Severe hepatic disease or other contraindications to acetaminophen use

          -  Patient has received acetaminophen within 24 hours of their procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Julie Rice-Weimer, RN</last_name>
    <phone>614-355-3142</phone>
    <email>julie.rice-weimer@nationwidechildrens.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Catherine Roth, MPH</last_name>
    <phone>614-722-2297</phone>
    <email>catherine.roth@nationwidechildrens.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 10, 2020</study_first_submitted>
  <study_first_submitted_qc>February 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2020</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>Peter Winch</investigator_full_name>
    <investigator_title>Associate Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

